Despite few patient samples showing mutations, and a lack of information on breast cancer subtypes, we found that prognostic genes identified by IPP, such as DONSON, MKI67, FAM171A1, TENM4, C16orf45, and RABEP2, showed statistically differences in survival probability between mutation and non-mutation groups (Supplementary Fig. 14). Here, RABEP2 is linked to breast carcinoma.